{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T16:01:30Z","timestamp":1768838490553,"version":"3.49.0"},"reference-count":20,"publisher":"S.C. JURNALUL PENTRU MEDICINA SI VIATA S.R.L","issue":"3","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JMedLife"],"DOI":"10.25122\/jml-2018-1002","type":"journal-article","created":{"date-parts":[[2019,3,13]],"date-time":"2019-03-13T11:52:26Z","timestamp":1552477946000},"page":"243-246","source":"Crossref","is-referenced-by-count":9,"title":["The role of noninvasive tests and liver biopsy in the diagnosis of nonalcoholic fatty liver disease"],"prefix":"10.25122","volume":"11","author":[{"given":"Craita","family":"Isabela Andronescu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Medical Center Memormed, Bucharest","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monica","family":"Roxana Purcarea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Clinical Nephrology Hospital \u201cCarol Davila\u201d, Bucharest","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Petru","family":"Aurel Babes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"University of Oradea, Faculty of Medicine and Pharmacy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Craita-Isabela Andronescu \u2013 MD, Diabetes, Nutrition and Metabolic Diseases Calea Plevnei no 3 E-mail: craita2000@yahoo.com","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10755","published-online":{"date-parts":[[2018,9]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","unstructured":"Diehl A.M, Day C. Cause, Pathogenesis and Treatment of Nonalcoholic Steatohepatitis. N. Engl. J. Med 2017: 2063\u201372","DOI":"10.1056\/NEJMra1503519"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Tapper EB, Lok S.F. Use of Liver Imaging and Biopsy in Clinical Practice. N. Engl. J. Med. 2015; 377: 756\u201368","DOI":"10.1056\/NEJMra1610570"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Bront EM, Janey CG, Di Bisceglie AM. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am. J. Gastroenterol. 1999; 94:2467\u201374","DOI":"10.1111\/j.1572-0241.1999.01377.x"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Ratziu V., Charlotte F., Heurtier A. et al. Sampling variability of liver biopsy in nonalcoholic fatty liver disease. Gastroenterology 2015; 128: 1898\u2013906","DOI":"10.1053\/j.gastro.2005.03.084"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Poynard T., Lenaour G., Vaillant JC et al. Liver biopsy analysis has a low level of performance for diagnosis of intermediate stages of fibrosis. Clin Gastroenterol Hepatol 2012; 10 (6): 657\u201363","DOI":"10.1016\/j.cgh.2012.01.023"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Angulo P., Kleiner DE, Dam\u2013Larsen S. et al. Liver fibrosis, but no other histologic features, is associated with long\u2013term outcomes of patients with nonalcoholic fatty liver disease. Gastroenterology 2015; 61: 1547\u201354","DOI":"10.1053\/j.gastro.2015.04.043"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Sheet SG, Flamm SL, Gordon FD, Chopra S. AST\/ALT ratio predicts cirrhosis in patients with chronic hepatitis C virus infection. Am. J. Gastroenterol. 1998; 93: 44\u20138","DOI":"10.1111\/j.1572-0241.1998.044_c.x"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Linzh, Xinyn, Dong QJ et al. Performance of the aspartate aminotransferase\u2013to platelet ratio index in for the staging of hepatitis C\u2013related fibrosis: an updated meta-analysis. Hepatology 2011; 53: 726\u201336","DOI":"10.1002\/hep.24105"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Tapper EB, Robson SC, Malik R. Coagulopathy in cirrhosis\u2013the role of the platelet in hemostasis. J Hepatol 2013; 59: 889\u201390","DOI":"10.1016\/j.jhep.2013.03.040"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Poynard T., Verginiol I., Ngo Y. et al. Staging chronic hepatitis C in severe categories using fibrosis biomarker (FibroTest) and transient elastography (Fibroscan). J. Hepatol 2014; 60: 706\u201314","DOI":"10.1016\/j.jhep.2013.11.016"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Tapper EB, Sengupta N, Huninck MG et al. Cost\u2013effectiveness: risk stratification of NAFLD by the primary care physician using the NAFLD fibrosis score. Plus One 2016; 11(2)","DOI":"10.1371\/journal.pone.0147237"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Allan R., Thoirs K., Phillips M. Accuracy of ultrasound to identify chronic liver disease. World J. Gastroenterol 2010; 16: 3510\u201320","DOI":"10.3748\/wjg.v16.i28.3510"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Tapper EB, Castera L, Afdahl NH. Fibroscan (vibration\u2013controlled transient elastography): Where does it stand in the United States practice. Clin Gastroenterol Hepatol 2015; 13: 27\u201336","DOI":"10.1016\/j.cgh.2014.04.039"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Chen J, Yin M, Talwalkar JA et al. Diagnostic performance of MR elastography and vibration\u2013controlled transient elastography in the detection of hepatic fibrosis in patients with severe to moderate obesity. Radiology 2017; 283: 418\u201328","DOI":"10.1148\/radiol.2016160685"},{"key":"ref15","unstructured":"Angulo P., Hui JM, Marchesini G. et al. The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD. Hepatol 2017; 7:1104\u201312"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Shah AG, Lipecker A., Murray K et al. Comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease. Clin. Gastroenterol. Hepatol.2009; 7: 1104\u201312","DOI":"10.1016\/j.cgh.2009.05.033"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"de Franchis R, Baveno VI, Faculty. Expanding Consensus in portal hypertension. J. Hepatol. 2015; 63: 743\u201352","DOI":"10.1016\/j.jhep.2015.05.022"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"Sorbi D., Boynton J., Lindor KD. The ratio of aspartate aminotransferase to alanine aminotransferase: potential value in differentiating nonalcoholic steatohepatitis from alcoholic liver disease. Am. J. Gastroenterol 1999; 94: 1018\u201322","DOI":"10.1111\/j.1572-0241.1999.01006.x"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"Skelly MM, James PD, Ryder SD. Findings on liver biopsy to investigate abnormal liver function tests in the absence of diagnostic serology. J. Hepatol 2001; 35: 195\u20139","DOI":"10.1016\/S0168-8278(01)00094-0"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"Daniel S., Ben Menachem T, Vasudevan G, Blumenkehl M. Prospective evaluation of unexplained chronic liver transaminase abnormalities in asymptomatic and symptomatic patients. Am J Gastroenterol 1999; 94: 3010\u20134","DOI":"10.1111\/j.1572-0241.1999.01451.x"}],"container-title":["Journal of Medicine and Life"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/medandlife.org\/wp-content\/uploads\/JMedLife-11-243.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,24]],"date-time":"2021-12-24T03:06:11Z","timestamp":1640315171000},"score":1,"resource":{"primary":{"URL":"https:\/\/medandlife.org\/wp-content\/uploads\/JMedLife-11-243.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":20,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["JMedLife-11-243"],"URL":"https:\/\/doi.org\/10.25122\/jml-2018-1002","relation":{},"ISSN":["1844-122X","1844-3117"],"issn-type":[{"value":"1844-122X","type":"print"},{"value":"1844-3117","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9]]}}}